KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Invested Capital (2016 - 2025)

Globus Medical (GMED) has disclosed Invested Capital for 15 consecutive years, with $4.4 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Invested Capital fell 2.39% year-over-year to $4.4 billion, compared with a TTM value of $4.4 billion through Sep 2025, down 2.39%, and an annual FY2024 reading of $4.6 billion, up 15.58% over the prior year.
  • Invested Capital was $4.4 billion for Q3 2025 at Globus Medical, up from $4.3 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $4.6 billion in Q4 2024 and bottomed at $1.6 billion in Q1 2021.
  • Average Invested Capital over 5 years is $3.0 billion, with a median of $2.0 billion recorded in 2023.
  • The sharpest move saw Invested Capital soared 137.36% in 2023, then decreased 5.94% in 2025.
  • Year by year, Invested Capital stood at $1.7 billion in 2021, then increased by 6.03% to $1.8 billion in 2022, then soared by 116.53% to $4.0 billion in 2023, then increased by 15.58% to $4.6 billion in 2024, then dropped by 4.8% to $4.4 billion in 2025.
  • Business Quant data shows Invested Capital for GMED at $4.4 billion in Q3 2025, $4.3 billion in Q2 2025, and $4.1 billion in Q1 2025.